How to plan a brain tumor MRI protocol (part 2: post-contrast)
Written by:
Erik Jacobsson
This step-by-step guide is for MRI students, radiographers, and technologists who wish to improve their planning skills and master the brain tumor MRI protocol.
This guide is Part 2 of planning a brain tumor MRI assessment. In Part 1, we covered pre-contrast imaging and tumor characterization.
In this Part 2, we will follow up with contrast injection and post-contrast imaging, where we identify enhancement patterns that guide tumor diagnosis and treatment planning.
What you will learn:
Key factors in brain tumor MRIs, including trade-offs.
How to perform the contrast injection workflow.
Best post-contrast pulse sequences and planning techniques.
Ways to avoid common artifacts.
Qualities of great brain tumor images.
Key Takeaways
Resolution and SNR are nearly equal priorities, with resolution slightly ahead.
Missing a 2 mm brain metastasis can completely change treatment decisions.
High spatial detail is essential to differentiate tumor types and detect infiltrative margins.
SNR is not a goal on its own, but it must be high enough to support the required resolution.
Scan time ranks third, unless patient motion becomes a problem.
Most patients tolerate around 30 minutes of scanning.
However, motion can make images completely unreadable.
For uncooperative patients, it is better to sacrifice some resolution or SNR than lose the entire study to motion blur.
Brain tumor protocols rely on many complementary sequences.
No single sequence gives a complete picture.
We apply T1 3D MP-RAGE for anatomy and contrast comparison, T2 for edema and cystic components,
FLAIR for infiltrative margins, diffusion-weighted imaging for cellularity,
and T2 star for hemorrhage.
Together, these contrasts reveal different tissue properties of the tumor.
Avoid these common brain tumor MRI artifacts.
Watch for motion, susceptibility, chemical shift, CSF flow, truncation, and wrap-around on the post-contrast sequences. Each has a specific fix, covered where the relevant sequence is planned below.
Intro to Post-Contrast Brain Tumor Imaging
In Part 1 of our brain tumor protocol, we completed all pre-contrast sequences. We captured baseline anatomical information with 3D MP-RAGE, assessed tumor composition with T2 and FLAIR, evaluated cellularity with diffusion-weighted imaging, and checked for hemorrhage with T2* gradient echo.
Now we continue with another core part of brain tumor assessment: contrast-enhanced imaging. This is where we identify enhancement patterns that guide diagnosis and treatment planning.
Enhancement patterns narrow the differential. They do not settle it, and the radiologist makes the call.
Rim enhancement: raises high-grade glioma, abscess, or metastasis
Homogeneous enhancement: raises meningioma, lymphoma, or some metastases
Nodular enhancement: raises hemangioblastoma or a complex cystic lesion
No enhancement: raises low-grade glioma, though some high-grade gliomas enhance minimally
These patterns directly impact treatment decisions and prognosis.
How to Balance the 3 Trade-offs in Brain Tumor MRIs
In MRI, we always face a trade-off between 3 key metrics:
Scan Time: How fast a pulse sequence can be completed.
Resolution: How much detail the image can display.
SNR: How clear the image is, meaning how much signal we have compared with noise.
Improving one of these metrics often reduces the performance of the others. To decide what trade-offs to make, we must consider the needs of each clinical situation.
For brain tumor MRIs, we face these challenges:
Missing a 2 mm metastasis could change treatment entirely. We need to see small lesions clearly and detect infiltrative margins that extend into normal brain tissue.
We must differentiate between different tumor types based on their signal characteristics. This requires adequate image clarity to distinguish subtle differences in tissue properties.
Brain tumor protocols are comprehensive studies that include many sequences. Most patients can tolerate around 30 minutes of scanning, but beyond that, motion artifacts can make images completely unreadable.
Therefore, we typically:
Prioritize resolution to detect small metastases and infiltrative margins,
Keep good SNR to ensure adequate image clarity for our resolution targets, and
Optimize scan time as needed to stay within the practical limit of around 30 minutes.
Note! Prioritizing resolution in brain tumor MRIs is only a general guideline, NOT a strict rule. If the patient cannot hold still, then scan time becomes the top priority, since it's better to sacrifice some resolution or SNR than to risk motion blur that makes images completely unreadable. The right balance always depends on factors such as field strength, patient cooperation, available hardware, and the clinical question.
Post-Contrast Brain Tumor Conditions and the MRI Sequences That Reveal Them
These are some of the most common brain tumor conditions we look for in post-contrast imaging, and which pulse sequences reveal them:
Fat suppression removes bright skull base fat and marrow signal.
This makes thin dural enhancement and the dural tail much easier to see.
The Contrast Injection Workflow
The whole workflow hinges on one rule: plan every post-contrast sequence before the contrast goes in. Anything left unplanned costs enhancement window.
For Manual Injection:
Insert cannula in patient's arm
Position patient at isocenter
Acquire all pre-contrast sequences
Plan all post-contrast sequences
Slide patient table out of bore
Enter scan room with prepared syringe
Inject contrast slowly through cannula
Press isocenter button to reposition patient
Return to control room and start post-contrast acquisitions 5 minutes after starting the injection
For Automated Power Injection:
Insert cannula in patient's arm
Connect IV line from injector to cannula
Position patient at isocenter
Acquire all pre-contrast sequences
Plan all post-contrast sequences
Set injection parameters (volume, flow rate, etc.)
Initiate injection from control room
Wait 5 minutes after starting the injection, then start post-contrast sequences
In both workflows, planning post-contrast sequences happens before contrast injection (Step 4 in the manual workflow, Step 5 in the automated workflow).
How to Perform Brain Tumor Contrast-Enhanced Imaging
The step-by-step guide below will show you how to perform contrast-enhanced imaging for brain tumor assessment, the second part of a complete brain tumor protocol.
In Part 1, we set up the patient, captured localizer images, and acquired all pre-contrast sequences. Now in Part 2, we will perform the protocol in 3 steps:
Plan and Set Up the Post-Contrast Sequences
Inject the Contrast Agent
Review the Images
Step 1: Plan and Set Up the Post-Contrast Sequences
Before we inject contrast, we must plan all post-contrast sequences and have them ready to run. This ensures we don’t waste any time after injection.
The 3 post-contrast sequences of a standard brain tumor MRI protocol:
Sagittal T1 3D MP-RAGE
Axial T1 TSE Fat-Sat (Post-Contrast)
Coronal T1 TSE Fat-Sat (Post-Contrast)
We use T1-weighted sequences after contrast because they show enhancement patterns that guide diagnosis.
A matched isotropic 3D T1 acquisition is central to post-contrast tumor imaging, and MP-RAGE is the sequence used here. The fat-suppressed T1 TSE sequences confirm enhancement patterns and remove fat signal that could obscure pathology.
In the sections below, we go through how to plan and set up each sequence.
1. Planning Sagittal T1 3D MP-RAGE (Post-Contrast)
✅ Correct Planning:
Planning Instructions:
Copy the slice geometry and planning from the pre-contrast sagittal T1 3D MP-RAGE sequence.
Keep the same slice angulation, coverage, and positioning to ensure precise comparison between pre- and post-contrast images.
Use identical spatial resolution and planning to enable side-by-side overlay comparison.
Parameters for Post-Contrast Sagittal T1 3D MP-RAGE:
Use the same parameters as the pre-contrast T1 3D MP-RAGE sequence, with one exception: parallel imaging is added here to keep the acquisition inside the enhancement window, which the pre-contrast sequence has no need to race against.
Parameter
Recommended Values
Why These Values
Echo Time (TE)
3–4 ms
Very short TE minimizes T2* effects and maximizes T1 contrast.
Repetition Time (TR)
1,800–2,500 ms
Long TR allows complete relaxation between inversion pulses in MP-RAGE sequence.
Inversion Time (TI)
800–900 ms
Maximizes gray-white matter contrast at 3 T.
Field of View (FOV)
230 × 230 mm
Square FOV for isotropic voxels, large enough to cover the entire brain.
Matrix
192 × 192
Gives 1.2 mm in plane, matching the slice thickness for isotropic voxels.
Foldover Direction (Phase)
Anterior-to-Posterior (AP)
Minimizes FOV in AP direction to reduce scan time while covering brain fully.
Slices
120–128
Covers the brain side to side at 1.2 mm, roughly 144 to 154 mm.
Slice Thickness
1.2 mm
Matches the matrix for isotropic voxels, at the finest resolution the available slice count can cover the brain with.
NEX / Averages
1
Single average keeps scan time reasonable while maintaining good SNR at 3T.
Flip Angle
15°
Low flip angle optimizes T1 contrast with short TR in gradient echo sequence.
Bandwidth per pixel
500–550 Hz/px
High enough to keep the readout short for a 4 ms TE, at some cost to SNR.
Parallel Imaging
GRAPPA, acceleration factor 2
Halves the phase-encoding steps to keep scan time down, at a modest SNR cost.
This is a 3D acquisition, so slices are contiguous, with no gap between them.
2. Planning Axial T1 TSE Fat-Sat (Post-Contrast)
✅ Correct Planning:
Planning Instructions:
Copy the slice geometry and planning from the axial T2 TSE sequence.
Keep the same slice angulation, coverage, and positioning to ensure images can be easily compared with other axial sequences.
Acquire this sequence directly after the 3D completes.
Parameters for Post-Contrast Axial T1 TSE Fat-Sat:
Parameter
Recommended Values
Why These Values
Effective TE
8–12 ms
Short TE is required for T1 contrast.
TR
300–450 ms
Short TR is required for T1 contrast.
Field of View (FOV)
230 × 230 mm
Matches the other axial sequences so the geometry can be copied.
Matrix
320 × 320
Same in-plane resolution as the other axial sequences.
Foldover Direction (Phase)
Right-to-Left (RL)
Confirmed once for the axial plane and applied to every axial sequence.
Slices
30–35
Covers vertex to foramen magnum at 4 mm with a 1 mm gap.
Slice Thickness
4 mm
Thin enough to resolve small enhancing lesions, while keeping enough signal per slice at three averages.
Slice Gap
1 mm
25% of slice thickness, which limits cross-talk without hiding anatomy.
NEX / Averages
3
Three averages support detection of faint enhancement, at a cost in scan time.
Turbo Factor / ETL
2–4
Kept short so the effective TE stays short, preserving T1-weighting.
Bandwidth per pixel
230–260 Hz/px
High enough to limit chemical shift, while keeping the SNR this sequence needs.
Parallel Imaging
GRAPPA, acceleration factor 2
Halves the phase-encoding steps to keep scan time down, at a modest SNR cost.
Fat Suppression
Spectral
Removes fat signal so enhancement near the skull base is not masked.
Foldover Suppression
No
No anatomy falls outside the FOV in the phase direction for the head coil to alias, so there is nothing to suppress.
Use the post-contrast sagittal T1 3D MP-RAGE for planning.
Align the slices as follows:
Sagittal Localizer: Perpendicular to the midsagittal line of the brain.
Axial Localizer: Ensure slices run from anterior (frontal lobe) to posterior (occipital lobe) without cutting out any anatomy.
Use appropriate geometry parameters:
Slice number: Enough to cover from the posterior fossa to the frontal lobe (typically 30–35 slices).
Slice thickness: 4 mm, medium thickness for good resolution without sacrificing scan time or SNR.
Slice gap: 1 mm, 25% of slice thickness, which limits cross-talk without hiding anatomy.
Set the fold-over direction (phase encoding) to right-left (RL) to minimize wraparound artifacts and allow the smallest field of view.
Acquire this sequence directly after the axial completes. Enhancement is weaker by this point, and fat suppression contributes more to the clarity of this sequence than the exact timing does.
Parameters for Post-Contrast Coronal T1 TSE Fat-Sat:
Parameter
Recommended Values
Why These Values
Effective TE
8–12 ms
Short TE is required for T1 contrast.
Repetition Time (TR)
350–600 ms
Short TR is required for T1 contrast.
Field of View (FOV)
230 × 220 mm
Optimized for coronal orientation covering brain from anterior to posterior.
Matrix
320 × 224
High matrix provides excellent spatial resolution for detecting small enhancing lesions.
Foldover Direction (Phase)
Right-to-Left (RL)
Minimizes wraparound artifacts and optimizes FOV for brain shape in coronal view.
Slices
30–35
Enough slices to fully cover from posterior fossa to frontal lobe.
Slice Thickness
4 mm
Medium thickness balances resolution with SNR and scan time.
Slice Gap
1 mm
25% of slice thickness, which limits cross-talk without hiding anatomy.
NEX / Averages
3
Higher averaging improves SNR for detecting subtle enhancement.
Turbo Factor / ETL
2–4
Kept short so the effective TE stays short, preserving T1-weighting.
Bandwidth per pixel
244 Hz/px
Medium bandwidth balances SNR with chemical shift artifacts.
Parallel Imaging
GRAPPA, acceleration factor 2
Halves the phase-encoding steps to keep scan time down, at a modest SNR cost.
Foldover Suppression
No
No anatomy falls outside the FOV in the phase direction for the head coil to alias, so there is nothing to suppress.
Fat Suppression
Spectral
Removes fat signal so enhancement near the skull base is not masked.
Note: If spectral fat suppression is non-uniform at 3 T, switch to a Dixon water-only reconstruction or another vendor-supported chemical method. Do not substitute STIR after contrast. STIR suppresses short-T1 tissue, and gadolinium shortens T1, so STIR can suppress the enhancement the sequence exists to show.
How to Avoid Artifacts When Planning the Sequences
The table below lists the 6 artifacts that affect the post-contrast sequences, and what techniques you can use to avoid them. See Part 1 for diffusion-related geometric distortion.
Artifacts
Solution – How to Avoid It
Motion artifacts
Shorten scan time to reduce patient movement.
Immobilize the head as much as possible to maintain image sharpness.
Susceptibility artifacts
Use spin echo sequences over gradient echo.
Position slices carefully to reduce effects from air-tissue interfaces.
Chemical shift artifacts
Increase the bandwidth to reduce spatial misregistration between fat and water signals.
CSF flow artifacts
Apply flow compensation gradients and fast sequences such as FLAIR
to reduce cerebrospinal fluid pulsation effects.
Truncation artifacts
Increase spatial resolution to capture more frequency information
and reduce Gibbs ringing at sharp tissue boundaries.
Wrap-around artifacts
Keep the field of view wide enough to contain the head in the phase direction, which is already the case here.
A dedicated head coil has little sensitivity beyond the head, so there is no anatomy left to alias, and foldover suppression stays off.
Step 2: Inject the Contrast Agent
Now that all post-contrast sequences are planned and ready, we proceed with contrast injection following the workflow outlined earlier.
1. Verify Patient Safety
Before any contrast injection, you must verify that the patient can handle it. Contrast safety follows local policy and the agent in use. For patients with acute kidney injury or an eGFR below 30 mL/min/1.73 m², the decision weighs the benefit of the study against the agent's risk group, and it belongs to the radiologist rather than the radiographer. A standard dose of a modern macrocyclic agent carries very low risk even at low eGFR, so a needed study should not be cancelled reflexively. Check the local cutoff and approval route before the patient arrives.
If contrast cannot be given safely, complete and report the pre-contrast series and discuss the case with the radiologist before ending the exam. Never compromise patient safety for imaging.
2. Contrast Dosing
The dose is prescribed in millimoles per kilogram, not in milliliters. The standard adult dose for brain imaging is 0.1 mmol/kg.
Convert to a volume using the concentration printed on the vial in front of you:
For an 80 kg patient the dose is 8 mmol, which gives:
Concentration
Example agents
Volume at 80 kg
0.5 mmol/mL
gadoterate, gadoteridol, gadobenate
16 mL
1.0 mmol/mL
gadobutrol
8 mL
Never carry a milliliter figure across from another site or another agent. Recalculate from the concentration on the vial every time.
3. Timing Protocol
After the injection, follow this order:
Wait 5 minutes from the start of the injection, so the contrast distributes into the tissue and the vessel signal fades.
Start the 3D MP-RAGE. It takes roughly 6 minutes.
Run the axial T1 with fat suppression directly after it completes. It takes roughly 6 minutes.
Run the coronal T1 directly after the axial completes.
Whichever delay your department uses before the first post-contrast sequence, use the same delay for every follow-up study, so the images stay comparable.
Step 3: Review the Post-Contrast Images
Note: This section only reviews the post-contrast images. The pre-contrast review is in the Part 1 article. The Part 2 video reviews both sets of images, since the pre-contrast review happens while the post-contrast sequences acquire.
Finally, we will review the images to ensure all the anatomical information we need is clear.
These key structures must be clearly visible in a brain tumor MRI:
Tumor location, margins, and extent
Mass effect and structural distortion
Ventricular compression or shift
Relationship to eloquent cortex and major vessels
Internal tumor composition (solid versus cystic)
Edema and infiltrative margins
Enhancement patterns
Below, we will go through all the different image contrasts and explain their specific role in imaging brain tumors.
Post-Contrast T1 3D MP-RAGE – Reveals Enhancement Patterns
A matched isotropic 3D T1 acquisition is central to post-contrast tumor imaging, and MP-RAGE is the sequence used here for detecting tumor enhancement and abnormal blood-brain barrier breakdown.
In brain tumor imaging, post-contrast T1 3D MP-RAGE reveals enhancement patterns that guide diagnosis and tumor grading. Rim enhancement with a central hypointense core suggests high-grade glioma, abscess, or metastasis. Homogeneous enhancement indicates meningioma, lymphoma, or some metastases.
Absence of enhancement suggests low-grade glioma, though some high-grade gliomas also show minimal enhancement. Nodular enhancement appears in hemangioblastomas and some cystic lesions. The thin 1.2 mm slices allow detection of subtle enhancement and enable multiplanar reconstructions for detailed assessment.
We acquire this sequence in sagittal orientation because it provides volumetric coverage that can be reconstructed in any plane while maintaining isotropic resolution.
✅ Sagittal T1 3D MP-RAGE (Post-Contrast) – Correct Image Example:
Things to Look for in Post-Contrast T1 3D MP-RAGE:
Enhancement pattern (rim, homogeneous, nodular, or absent)
Dural tail sign suggesting meningioma
Vascular encasement or invasion
Small enhancing foci scattered through the parenchyma, which can indicate metastases, lymphoma, or infection
Compare carefully with pre-contrast T1 to distinguish true enhancement from intrinsic T1 hyperintensity
Post-contrast T1 with fat suppression reduces bright signal from fat, making true contrast enhancement stand out more clearly.
In brain tumor imaging, axial post-contrast T1 with fat suppression confirms enhancement patterns seen on the 3D MP-RAGE from a different angle. Fat suppression removes bright fat signal so enhancement near the skull base and in extra-axial tumors is not masked. It does not separate enhancement from hemorrhage, which the matched pre-contrast and post-contrast T1 images show instead. This sequence is acquired directly after the 3D, while parenchymal enhancement is still strong, making subtle tumor enhancement more visible.
We acquire this sequence in axial orientation to match other standard axial sequences and enable direct comparison with pre-contrast images.
Post-contrast coronal T1 with fat suppression provides a frontal perspective of tumor enhancement with fat signal suppressed.
In brain tumor imaging, coronal post-contrast T1 with fat suppression assesses the superior-inferior extent of the tumor and its enhancement. This view is particularly useful for identifying dural involvement, meningeal spread, and skull base invasion. Fat suppression clarifies enhancement along the meninges and skull base where fat might otherwise obscure pathology. This sequence complements the sagittal and axial post-contrast images for complete three-dimensional assessment.
We acquire this sequence in coronal orientation to complete the three orthogonal planes and provide optimal assessment of superior-inferior tumor relationships.
Things to Look for in Post-Contrast Coronal T1 with Fat Suppression:
Superior-inferior tumor extent and enhancement
Dural involvement or meningeal spread along brain surface
Skull base invasion
Relationship to cranial nerves and vascular structures
Final Checks
Before finishing a post-contrast brain tumor MRI, always check these 6 points to ensure diagnostic quality:
Pre- and Post-Contrast Comparison: Pre-contrast and post-contrast T1 images must have identical planning to enable accurate comparison and enhancement assessment.
Complete Coverage: All sequences must fully cover the entire tumor and surrounding brain tissue, with no anatomical structures cut off.
Enhancement Pattern Clarity: Post-contrast images must clearly show enhancement patterns, with the post-contrast series started after the department's standard delay, and the same delay used for every follow-up study.
Multiplanar Assessment: Tumor must be evaluated in all three planes (axial, sagittal, coronal) for complete spatial understanding.
Fat Suppression Quality: Post-contrast sequences with fat suppression must show uniform fat suppression, making true enhancement clearly visible.
Image Quality and Artifacts: Images must have strong SNR, crisp detail, and minimal motion, chemical shift, susceptibility, or wrap-around artifacts. Motion artifacts matter most in brain tumor protocols, because the study runs long.